Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Biotech Portfolio Updates- Buying More Immunogen
Oct 16, 2008 10:01 AM
- Immunogen – Lost In Translation
Oct 15, 2008 12:09 PM
- When There Is Blood In The Streets - Buy Biotech
Oct 10, 2008 07:37 PM
- Immunogen: The Time Has Come
Sep 23, 2008 11:25 AM
- Exelixis as a Platform Company
Sep 03, 2008 01:34 AM
- Another Seal of Approval For Micromet
Aug 19, 2008 10:52 AM
- Genentech’s Shiny New Platform
Aug 06, 2008 04:33 AM
- Immunogen at ASCO Annual Meeting 2008
Jul 15, 2008 08:41 AM
- Immunogen and Seattle Genetics – On The Verge Of An Inflection Point
May 24, 2008 12:35 PM
- Protalix BioTherapeutics to Present at Three International Healthcare Conferences and ImmunoGen, Inc. Announces Presentations at Upcoming 2008 American Society of Clinical Oncology Annual Meeting
May 23, 2008 12:59 PM
- ImmunoGen, Inc. Announces Webcast of Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference
Nov 11, 2008 06:32 AM
- ImmunoGen, Inc. Appoints James J. O'Leary, MD, as Vice President and Chief Medical Officer
Nov 10, 2008 06:31 AM
- ImmunoGen, Inc. Earns $4 Million Milestone Payment with sanofi-aventis' Initiation of a Phase II Trial with AVE1642
Oct 27, 2008 04:11 PM
- ImmunoGen, Inc. Reports First Quarter Fiscal Year 2009 Financial Results
Oct 27, 2008 04:04 PM
- ImmunoGen, Inc. Announces Webcast of Presentation at the 7th Annual BioInvestor Forum
Oct 23, 2008 06:32 AM
- ImmunoGen, Inc. Announces Bayer HealthCare Has Licensed Rights to TAP Technology for a Solid Tumor Target
Oct 21, 2008 06:33 AM
- ImmunoGen, Inc. Announces Conference Call to Discuss its First Quarter Fiscal Year 2009 Financial Results
Oct 20, 2008 06:32 AM
- ImmunoGen, Inc. Announces Presentations at Upcoming EORTC-NCI-AACR Symposium
Oct 14, 2008 12:31 PM
- ImmunoGen, Inc. Announces CEO Succession Plan
Sep 30, 2008 06:32 AM
- ImmunoGen, Inc. to Present at Upcoming Investor Conferences
Sep 29, 2008 06:31 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
IMGN
|
Compare to S&P
|
| YTD |
-7.95 %
|
50.81 %
|
| 4 Weeks |
-17.50 %
|
-10.82 %
|
| 12 Weeks |
-26.54 %
|
1.83 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 29.63 %
|
|
EPS Growth in Last Year: -850.00 %
|
|
Sales Growth in Last Quarter: 36.65 %
|
|
Sales Growth in Last Quarter: -46.38 %
|
|
|
